Neuroscience Strategic Roundup

Neuroscience Strategic Roundup | June17–July 21, 2026

Strategic Developments and Competitive Shifts in Neuroscience Coverage Period:…


Lucid Diligence Brief - BioPharma

Servier Completes Edgewise Muscular Dystrophy Acquisition | Lucid Diligence Brief

Servier Completes the Edgewise Muscular Dystrophy Acquisition and Adds…


Lucid Diligence Brief - BioPharma

Vedana Therapeutics Advances Migraine Antibody Pipeline | Lucid Diligence Brief

Vedana Therapeutics has emerged from stealth with $46 million in Series A…


Lucid Diligence Brief - BioPharma

Servier Edgewise Sevasemten Deal | Lucid Diligence Brief

Servier’s Edgewise acquisition puts sevasemten’s Becker muscular dystrophy data…


Public_Health

Public Health Today—May 1, 2026

This is a weekly update in public health, highlighting advances across clinical…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Eli Lilly Pipeline Rationalization

Lucid Diligence Brief: Eli Lilly Pipeline Rationalization Professional…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Sanofi and ADEL sign global licensing deal in Alzheimer's

Lucid Diligence Brief: Sanofi and ADEL sign global licensing deal in…


Rare Disease news

Rare Diseases Weekly News - August 7th 2025

🧬 This Week in Rare Diseases: Europe’s R&D at Risk, AI Drug Discovery, New…


AAN 2025 Social Media Report

Trending at AAN 2025: Social Media Insights from X

📊 AAN 2025 Social Media Insights 📥 Download the Full Report! Dive deeper


Women's_Health

Women's Health Weekly News - June 11th 2025

Women’s Health Update: From Ground-Breaking Antidepressant Results to Policy…


Public_Health

Public Health Weekly News - May 16th 2025

Latest Public Health Updates: Weight Loss, Inverse Vaccines, Alzheimer’s &…


ASCGT 2025 PREVIEW

ASGCT 2025 Preview

🔬 ASGCT 2025: Transforming Medicine with Gene Editing, Cell Therapies &……


Privacy Preference Center